Insmed Incorporated
Insmed Incorporated (INSM) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
insm · pe ratio · data through Dec 31, 2025
Core PE Ratio Metrics
Trailing 12 months · TTMThe price-to-earnings (P/E) ratio for Insmed Incorporated (INSM) measures how much investors pay for each dollar of the company's trailing earnings. INSM's current PE ratio of N/A is calculated by dividing its stock price of $94.97 by its TTM earnings per share of -$5.49.
Source: FMP · /ratios-ttm · /analyst-estimates · 2025-12-31
PE Ratio History
2006 – 2025 · Annual▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)
PE Ratio vs Peers
Biotechnology · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
Insmed IncorporatedYou INSM | $20.6B | N/A | — | -$5.49 |
 Agilent Technologies, Inc. A | $38.0B | 31.79x | +17.7% | $4.60 |
 Alcon Inc. ALC | $32.5B | 39.80x | +47.3% | $1.98 |
 Cardinal Health, Inc. CAH | $48.2B | 25.94x | -4.0% | $6.48 |
 GE HealthCare Technologies Inc. GEHC | $29.5B | 17.97x | -33.5% | $4.56 |
 Haleon plc HLN | $39.6B | 20.62x | -23.7% | $0.36 |
 Humana Inc. HUM | $41.9B | 25.97x | -3.9% | $9.86 |
Industry Average 6 peers with valid PE | — | 27.01x | baseline | — |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
Annual PE Ratio History
| Fiscal Year End | PE Ratio | EPS (TTM) | YoY Change | PE vs Max |
|---|---|---|---|---|
2025-12-31Latest FY2025 | — | $-5.98 | — | |
2024-12-31 FY2024 | — | $-5.57 | — | |
2023-12-31 FY2023 | — | $-5.34 | — | |
2022-12-31 FY2022 | — | $-3.91 | — | |
2021-12-31 FY2021 | — | $-3.88 | — | |
2020-12-31 FY2020 | — | $-3.01 | — | |
2019-12-31 FY2019 | — | $-3.01 | — | |
2018-12-31 FY2018 | — | $-4.22 | — | |
2017-12-31 FY2017 | — | $-2.89 | — | |
2016-12-31 FY2016 | — | $-2.85 | — |
▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for Insmed Incorporated (INSM) measures how much investors pay for each dollar of the company's trailing earnings. INSM's current PE ratio of N/A is calculated by dividing its stock price of $94.97 by its TTM earnings per share of -$5.49.
Frequently asked questions
INSM pe ratio · 6 questionsINSM's current PE ratio is N/A as of 2026-06-08, based on a stock price of $94.97 and TTM EPS of -$5.49. Data sourced from Financial Modeling Prep via INSM's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Insmed Incorporated SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-08